CVS settles for $36.5M over false Medicaid insulin claims, Minnesota recovers $400K

Minnesota will share in settlement after CVS doctored its insulin bills

Minnesota will receive a share of a $36.5 million national settlement with CVS after the pharmacy giant accepted responsibility for over-billing government-funded healthcare programs, including Medicare and Medicaid, for insulin pens, according to Fox 9. Minnesota’s share amounts to more than $850,000, including more than $400,000 in direct restitution to the state’s Medicaid program. “Insulin isn’t a luxury, it’s a medication people need to liv…

CVS is set to pay Minnesota in Medicaid settlement

CVS Pharmacy will pay Minnesota more than $850,000 as part of a nationwide settlement over allegations of false Medicaid claims.

Minnesota gets slice of CVS Medicaid overbilling settlement

The pharmacy chain deal comes as national concern over health care fraud intensifies.

CVS inks $440M deal to resolve improper billing case (CVS:NYSE)

CVS Health (CVS) and its subsidiary Omnicare will pay $440M to settle a case that alleged the senior care pharmacy improperly billed the government. Read more here.

CVS to pay $850K to Minnesota over insulin overbilling

Minnesota Attorney General Keith Ellison announced the settlement Thursday, which includes a coalition of 37 attorneys general and the federal government.

CVS settles for $36.5M over false Medicaid insulin claims, Minnesota recovers $400K

Minnesota Attorney General Keith Ellison announced a settlement with CVS, holding the pharmacy chain accountable for years of alleged overbilling related to insulin pens.